Editorial by Prof Nikolaos Papanikolaou, Scientific manager of the ProCAncer-I project ProCAncer-I is a collaborative project that combines the efforts of 20 clinical and technical partners in Europe and US. The focus is to collect the biggest in size, diverse dataset...
Newsletter #3
UC2: Characterization of cancer according to its biological aggressiveness
Βy Prof. Daniele Regge, Chief of the Radiology Unit, Candiolo Cancer Institute Patients diagnosed with localised prostate cancer (PCa) are classified in different risk groups, i.e. low, intermediate or high risk, and this choice will affect treatment and...
The Annotation tool
by Quibim Quibim set out to transform prostate diagnosis and monitoring by developing a new non-invasive imaging tool using MRI data and advanced computer models to investigate the prostate anatomy in extreme detail. The company has developed AI algorithms for...
Curating the data curation tool
by Advantis Medical Imaging Curating datasets is not an easy task. On the contrary, it can bring about hard-to-solve problems and lead to open-ended discussions, until a satisfactory solution is found. In ProCAncer-I, the curation of medical images has been a...
The largest collection of PCa multi-parametric anonymized image data worldwide
Interview with Prof Luis Martí-Bonmatí. Director of the Clinical Area of Medical Imaging Department at La Fe Polytechnic and University Hospital and Head of Radiology Department at QuironSalud Hospital in Valencia In ProCAncer-I you advertise that the platform that...
Advisory Board
Prof. Vincenzo Valentini is Professor of Radiation Oncology at the Faculty of Medicine of the Università Cattolica S.Cuore in Rome and Director of the Department of Radiology, Radiation Oncology and Haematology at the Policlinico Universitario A.Gemelli-IRCCS in Rome....
Presentation of partner QUIBIM, QUantitative Imaging Biomarkers In Medicine
Quibim is the go-to imaging partner bringing virtual biopsies to diagnostics and drug discovery. By following an AI-first approach to help detect pathologies and predict outcomes in oncology/immunotherapy, rheumatology and neurology. The company is specialized in...
Presentation of partner University of Pisa – The Imaging Lab
The University of Pisa is an Italian public research university located in Pisa, Italy. It was founded in 1343 by an edict of Pope Clement VI. It is the 19th oldest extant university in the world and the 10th oldest in Italy. The university is ranked within the top 10...
Presentation of partner Hacettepe University – Department of Radiology
The Radiology Department of the Hacettepe University is located in Ankara, Turkey. With decades of experience, all radiologic imaging procedures as well as interventional radiology services in scope of modern medicine are performed by the experienced and specialized...
Newsletter #3 Contents
Highlights
ProCAncer-I at the first EIT Health Morning Talks in Bosnia and Herzegovina
Dec 3, 2024
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
ProCAncer-I at the EMUC24 in Lisbon
Oct 1, 2024
The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...
Third Dissemination Event of the ProCAncer-I Project in Athens
May 30, 2024
ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...
AI in PCa imaging : The current status and future perspectives
Apr 29, 2024
Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...